MARKET

FBIOP

FBIOP

Fortress Biotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

20.13
-0.02
-0.10%
Closed 16:00 09/20 EDT
OPEN
20.14
PREV CLOSE
20.15
HIGH
20.40
LOW
19.90
VOLUME
9.11K
TURNOVER
--
52 WEEK HIGH
21.95
52 WEEK LOW
11.90
MARKET CAP
1.39B
P/E (TTM)
-18.0107
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of FBIOP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

FBIOP News

  • Checkpoint Therapeutics Added to Russell 2000?? Index
  • GlobeNewswirePNW.07/01 12:31
  • Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study...
  • GlobeNewswirePNW.06/03 11:01
  • Mustang Bio and St. Jude Children???s Research Hospital to Participate in Panel Discuss...
  • GlobeNewswirePNW.05/23 12:32
  • Will Fortress Biotech to Surge Higher?
  • Zacks.comZAK.05/17 14:12

More

Industry

Pharmaceuticals
+1.04%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About FBIOP

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
More

Webull offers Fortress Biotech Inc (FBIOP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.